Breaking News Instant updates and real-time market news.

USO

United States Oil Fund

$11.04

0.54 (5.14%)

, XOM

Exxon Mobil

$72.29

0.25 (0.35%)

12:09
01/09/19
01/09
12:09
01/09/19
12:09

Saudi Arabia expects Aramco IPO in 2021 following delay, CNBC reports

Saudi Energy Minister and Aramco Chairman Khalid al-Falih said on Wednesday that the kingdom expects the initial public offering for Aramco to take place in 2021, following a delay, according to CNBC. The report also added that Saudi Arabia's massive oil and gas reserves are even bigger than previously reported, according to an outside assessment commissioned by the kingdom. The independent audit not only revises Saudi reserves higher, but also shows national oil giant Saudi Aramco is taking strides toward transparency as it continues to consider a stock market debut, the publication said. Reference Link

USO

United States Oil Fund

$11.04

0.54 (5.14%)

XOM

Exxon Mobil

$72.29

0.25 (0.35%)

CVX

Chevron

$113.40

1.67 (1.49%)

RDS.A

Royal Dutch Shell

$60.77

0.52 (0.86%)

RDS.B

Royal Dutch Shell

$62.23

0.43 (0.70%)

TOT

Total

$55.40

1.195 (2.20%)

COP

ConocoPhillips

$65.89

1.59 (2.47%)

BP

BP

$40.36

0.33 (0.82%)

  • 09

    Jan

  • 01

    Feb

  • 10

    Feb

  • 28

    May

USO United States Oil Fund
$11.04

0.54 (5.14%)

XOM Exxon Mobil
$72.29

0.25 (0.35%)

11/26/18
WOLF
11/26/18
UPGRADE
WOLF
Outperform
Exxon Mobil upgraded to Outperform from Peer Perform at Wolfe Research
11/20/18
11/20/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Exxon Mobil (XOM) downgraded to Underperform from Market Perform at Raymond James with analyst Pavel Molchanov saying Exxon Mobil is "one of the least appealing ways to play" the firm's bullish oil call, particularly following the recent oil price selloff. 2. Skyworks (SWKS) downgraded to Underperform from Neutral at BofA/Merrill with analyst Vivek Arya citing limited content gains in 2019 iPhones. 3. Micron (MU) downgraded two notches to Underperform from Outperform at Baird with analyst Tristan Gerra saying he now models eight consecutive quarters of gross margin and EPS contraction given the continued deterioration in both DRAM and NAND memory pricing. 4. Nvidia (NVDA) downgraded to Underperform from Neutral at Exane BNP Paribas. 5. Western Digital (WDC) downgraded to Neutral from Positive at Susquehanna with analyst Mehdi Hosseini saying he has lost confidence in the company's ability to benefit from SSD substitution of HDDs. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/20/18
11/20/18
DOWNGRADE

Underperform
Exxon Mobil downgraded to Underperform at Raymond James
As previously reported, Raymond James downgraded Exxon Mobil to Underperform from Market Perform. Analyst Pavel Molchanov said Exxon Mobil is "one of the least appealing ways to play" the firm's bullish oil call, particularly following the recent oil price selloff. Molchanov believes Exxon shares will be a source of funds and notes free cash flow yield is below peer group median and is the only supermajor that is not returning capital to shareholders through buybacks.
11/20/18
RAJA
11/20/18
DOWNGRADE
RAJA
Underperform
Exxon Mobil downgraded to Underperform from Market Perform at Raymond James
CVX Chevron
$113.40

1.67 (1.49%)

11/05/18
11/05/18
UPGRADE
Target $138

Outperform
Chevron upgraded to Outperform on continued execution at Credit Suisse
As previously reported, Credit Suisse analyst William Featherston upgraded Chevron to Outperform from Neutral, with a $138 price target, citing continued execution, free cash flow visibility and compelling valuation. The analyst believes the company continues to execute on its already superior growth outlook, which should translate into better than expected capital efficiencies into 2019 and sets up for continued robust free cash flow. He sees upside to 2019-2020 volume forecasts supported by strong Permian growth, driving an estimated about $10B-$11B per annum of surplus free cash flow generation, which should enable Chevron to sustain competitive dividend growth and expand the scope of its current share buyback program.
11/05/18
FBCO
11/05/18
UPGRADE
FBCO
Outperform
Chevron upgraded to Outperform from Neutral at Credit Suisse
10/22/18
SIMM
10/22/18
INITIATION
Target $139
SIMM
Overweight
Chevron assumed with an Overweight at Simmons
Simmons analyst Blake Fernandez assumed Chevron with an Overweight rating and a price target of $139 as part of his broader research note on Integrated Oils, suggesting that the industry stands to benefit from the current stage of the energy cycle. Fernandez adds that Chevron is his Top Idea given that it had the worst year-to-date equity performance in the peer group and expects the stock to "play catch-up". The analyst further points to the company's "ample Permian takeaway capacity" as alleviation of "industry bottlenecks next year could prompt fund rotation back into equities with leverage" to the region.
10/03/18
REDB
10/03/18
DOWNGRADE
REDB
Neutral
Chevron downgraded to Neutral from Buy at Redburn
Redburn analyst Rob West downgraded Chevron to Neutral from Buy with a $115 fair value, down from $130 saying it benefits less from tightness in gas and increasing late cycle risks.
RDS.A Royal Dutch Shell
$60.77

0.52 (0.86%)

12/18/18
WELS
12/18/18
INITIATION
Target $76
WELS
Outperform
Royal Dutch Shell initiated with an Outperform at Wells Fargo
Wells Fargo analyst Roger Read started Royal Dutch Shell with an Outperform rating and $76 price target.
12/10/18
DBAB
12/10/18
DOWNGRADE
DBAB
Hold
Royal Dutch Shell downgraded to Hold from Buy at Deutsche Bank
Deutsche Bank analyst Lucas Herrmann downgraded Royal Dutch Shell to Hold and lowered his price target for the shares tp GBP 2,650 from GBP 2,800. The analyst believes that the less certain oil price "backcloth" will bring questions about the sustainability of both the company's buyback and 2020 CFFO guidance.
10/22/18
SIMM
10/22/18
INITIATION
Target $72
SIMM
Neutral
Royal Dutch Shell assumed with a Neutral at Simmons
Simmons analyst Blake Fernandez assumed Royal Dutch Shell with a Neutral rating and a price target of $72 as part of his broader research note on Integrated Oils, suggesting that the industry stands to benefit from the current stage of the energy cycle. Fernandez notes that the company enjoyed stronger than expected earnings last year, but its past couple of quarters have been underwhelming because of "multiple transitory culprits driving results including tax, derivatives, etc." The analyst prefers to wait for a reversal of this trend before becoming more constructive on the stock.
12/18/18
12/18/18
INITIATION
Target $76

Outperform
Wells Fargo starts Royal Dutch Shell at Outperform with $76 price target
As previously reported, Wells Fargo analyst Roger Read started Royal Dutch Shell with an Outperform rating and $76 price target, citing its attractive valuation, "relatively modest" reinvestment ratio and leading cash returns. He projects Shell's ROACE will essentially double to roughly 14% by 2020 versus 2017 levels based on a combination of higher production, cost-cutting, high grading of the portfolio and some degree of commodity price recovery, Read tells investors.
RDS.B Royal Dutch Shell
$62.23

0.43 (0.70%)

08/31/18
08/31/18
NO CHANGE

On The Fly: Top five analyst actions
Catch up on today's top five analyst actions with this list compiled by The Fly: 1. BP (BP) and Royal Dutch Shell (RDS.A) were upgraded to Hold from Underperform at Santander. 2. Dollar Tree (DLTR) downgraded to Market Perform from Outperform at Telsey Advisory. 3. Electronic Arts (EA) and Activision Blizzard (ATVI) were downgraded to Neutral from Buy at BofA/Merrill. 4. Gain Capital (GCAP) initiated with a Neutral at JPMorgan. 5. Avaya (AVYA) initiated with a Neutral at Citi. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
TOT Total
$55.40

1.195 (2.20%)

11/28/18
JPMS
11/28/18
UPGRADE
JPMS
Neutral
Total upgraded to Neutral from Underweight at JPMorgan
JPMorgan analyst Christyan Malek upgraded Total SA to Neutral from Underweight but lowered his price target to EUR49 from EUR54.
12/10/18
DBAB
12/10/18
UPGRADE
DBAB
Buy
Total upgraded to Buy from Hold at Deutsche Bank
Deutsche Bank analyst Lucas Herrmann upgraded Total to Buy while lowering his price target for the shares to EUR 54 from EUR 56. The analyst sees "robust cash flow growth" in 2019 for Total.
12/11/18
BOFA
12/11/18
UPGRADE
BOFA
Buy
Total upgraded to Buy from Neutral at BofA/Merrill
12/11/18
12/11/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. AT&T (T) upgraded to Buy from Neutral at Citi with analyst Michael Rollins saying he expects AT&T to further benefit from the "measured" promotional environment in wireless, while improving its competitive position from FirstNet and the marketing of its network enhancements, branded 5G Evolution. 2. Sanofi (SNY) upgraded to Buy from Hold at Jefferies with analyst Peter Welford saying he believes European large-cap pharmaceuticals are entering a period of sustained earnings momentum which should justify valuations above the historic average for the sector. 3. Total (TOT) upgraded to Buy from Neutral at BofA/Merrill. 4. Zynga (ZNGA) upgraded to Outperform from Neutral at Macquarie. 5. Allstate (ALL) upgraded to Hold from Sell at Edward Jones. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
COP ConocoPhillips
$65.89

1.59 (2.47%)

10/29/18
10/29/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Ford (F) upgraded to Buy from Neutral at Goldman Sachs with analyst David Tamberrino saying he views the stock as a "product and self-help story" along with an "attractive" dividend yield. 2. Helmerich & Payne (HP) upgraded to Market Perform from Underperform at BMO Capital. 3. STMicroelectronics (STM) upgraded to Neutral from Sell at UBS. 4. AB InBev (BUD) upgraded to Outperform from Sector Perform at RBC Capital with analyst James Edwardes Jones saying while the company's Q3 results were "disappointing," he believes that shares were also oversold given that the company's "sales growth looks OK relative to the rest of the consumer staples sector." 5. ConocoPhillips (COP) upgraded to Buy from Neutral at BofA/Merrill with analyst Doug Leggate saying ConocoPhillips' has a favorably leveraged oil portfolio mix which is overlooked by the market and benefits from the 2014 change in the Alaska tax regime. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
12/10/18
WOLF
12/10/18
UPGRADE
WOLF
Outperform
ConocoPhillips upgraded to Outperform from Peer Perform at Wolfe Research
12/14/18
TUDR
12/14/18
UPGRADE
TUDR
Buy
ConocoPhillips upgraded to Buy from Hold at Tudor Pickering
01/04/19
BOFA
01/04/19
DOWNGRADE
Target $72
BOFA
Neutral
ConocoPhillips downgraded to Neutral from Buy at BofA/Merrill
BofA/Merrill analyst Doug Leggate downgraded ConocoPhillips to Neutral from Buy and lowered its price target to $72 from $82 saying risk/reward is balanced between downside to strip prices and the firm's Brent base case of $65/bbl. Leggate acknowledges a recovery in oil prices could lead to material upside, but views volatility as the biggest challenge as too many stocks are competing for shrinking investor dollars.
BP BP
$40.36

0.33 (0.82%)

12/21/18
EVER
12/21/18
NO CHANGE
Target $42
EVER
Outperform
Golar LNG Tortue project worth $10 per share to equity, says Evercore ISI
After Kosmos Energy (KOS) and BP (BP), the equity owners in the Greater Tortue Ahmeyim project offshore Senegal and Mauritania, announced Final Investment Decision on Phase 1, which will utilize one of Golar LNG's (GLNG) FLNG vessels, Evercore ISI analyst Jonathan Chappell said he continues to estimate a nearly $10/share value to Golar LNG equity based on the expected output, start-up time, and financing. Stating that Tortue means "an awful lot" for Golar LNG, he reiterated his Outperform rating on the stock and trimmed his target to $42 from $43.
12/18/18
12/18/18
INITIATION
Target $41

Market Perform
Wells Fargo starts BP at Market Perform with $41 price target
As previously reported, Wells Fargo analyst Roger Read started BP with a Market Perform rating and $41 price target, citing his expectation that BP's total cash shareholder returns will trail its peer group through 2021. Despite an attractive valuation and production growth potential, BP's higher balance sheet leverage is a headwind to outperforming the market, Read tells investors.
12/18/18
WELS
12/18/18
INITIATION
Target $41
WELS
Market Perform
BP initiated with a Market Perform at Wells Fargo
Wells Fargo analyst Roger Read started BP with a Market Perform rating and $41 price target.
11/20/18
11/20/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. LyondellBasell (LYB) upgraded to Outperform from Sector Perform at RBC Capital with analyst Arun Viswanathan saying the shares look attractive when investors "look through oil and market volatility," anticipating the company to post "robust" EBITDA growth in 2019 and 2020. 2. BP (BP) upgraded to Outperform from Market Perform at Raymond James with analyst Jean-Pierre Dmirdjian saying poor year-to-date share performance has created an attractive entry point. He also said shares screen well on free cash flow, oil leverage, and production growth. 3. CME Group (CME) upgraded to Buy from Hold at Berenberg with analyst Chris Turner saying he expects "unsettled markets" in 2019 to provide a supportive backdrop for volumes in CME's core interest rate and currency products. 4. American Vanguard (AVD) upgraded to Buy from Hold at Loop Capital with analyst Chris Kapsch saying despite "much negativity" surrounding the broader agriculture end market amid the ongoing Trump/China trade war, American Vanguard is "navigating and executing admirably." 5. EQT Corporation (EQT) upgraded to Buy from Neutral at Goldman Sachs with analyst Brian Singer saying he believes the company's production guidance calling for 5% asset sale-adjusted growth in 2019 is conservative. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

ETFC

E-Trade

$48.89

0.65 (1.35%)

09:25
02/23/19
02/23
09:25
02/23/19
09:25
Conference/Events
E-Trade to hold Education Day »

Education Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

CAT

Caterpillar

$138.77

-0.08 (-0.06%)

, XRX

Xerox

$31.50

0.16 (0.51%)

08:29
02/23/19
02/23
08:29
02/23/19
08:29
On The Fly
Week in review: How Trump's policies moved stocks »

Catch up on the top…

CAT

Caterpillar

$138.77

-0.08 (-0.06%)

XRX

Xerox

$31.50

0.16 (0.51%)

DDAIF

Daimler AG

$0.00

(0.00%)

FCAU

Fiat Chrysler

$14.81

0.02 (0.14%)

F

Ford

$8.71

(0.00%)

GM

General Motors

$39.98

0.35 (0.88%)

HMC

Honda

$28.17

0.43 (1.55%)

NSANY

Nissan

$0.00

(0.00%)

TM

Toyota

$121.84

0.66 (0.54%)

VLKAY

Volkswagen

$0.00

(0.00%)

NYT

New York Times

$31.51

-0.62 (-1.93%)

LUV

Southwest

$53.62

-0.69 (-1.27%)

VZ

Verizon

$56.95

0.81 (1.44%)

TMUS

T-Mobile

$73.17

-0.09 (-0.12%)

T

AT&T

$31.15

0.32 (1.04%)

NOK

Nokia

$6.21

0.06 (0.98%)

ERIC

Ericsson

$9.51

0.285 (3.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 25

    Feb

  • 28

    Feb

  • 03

    Mar

  • 03

    Mar

  • 04

    Mar

  • 11

    Mar

  • 13

    Mar

  • 20

    Mar

  • 27

    Mar

  • 25

    Apr

  • 24

    Jul

  • 23

    Oct

AIMT

Aimmune

$23.70

0.73 (3.18%)

, AZN

AstraZeneca

$40.95

0.515 (1.27%)

04:55
02/23/19
02/23
04:55
02/23/19
04:55
Conference/Events
The American Academy of Asthma, Allergy & Immunology to hold annual meeting »

AAAAI Annual Meeting 2019…

AIMT

Aimmune

$23.70

0.73 (3.18%)

AZN

AstraZeneca

$40.95

0.515 (1.27%)

TEVA

Teva

$17.28

0.03 (0.17%)

NVS

Novartis

$90.77

0.26 (0.29%)

DNA

Bought by RHHBY

$0.00

(0.00%)

SHPG

Shire

$0.00

(0.00%)

REGN

Regeneron

$422.43

3.77 (0.90%)

SNY

Sanofi

$41.20

-0.13 (-0.31%)

ALK

Alaska Air

$62.35

-0.48 (-0.76%)

ABT

Abbott

$76.40

1.26 (1.68%)

CVS

CVS Health

$62.00

-0.33 (-0.53%)

KALV

KalVista

$20.74

-0.04 (-0.19%)

BCRX

BioCryst

$8.99

0.32 (3.69%)

OPTN

Optinose

$7.31

0.02 (0.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 27

    Feb

  • 28

    Feb

  • 28

    Feb

  • 04

    Mar

  • 04

    Mar

  • 04

    Mar

  • 07

    Mar

  • 11

    Mar

  • 11

    Mar

  • 12

    Mar

  • 18

    Mar

  • 19

    Mar

  • 22

    Mar

  • 28

    Apr

  • 13

    May

  • 18

    May

ETFC

E-Trade

$48.89

0.65 (1.35%)

04:55
02/23/19
02/23
04:55
02/23/19
04:55
Conference/Events
E-Trade to hold Education Day »

Education Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

TEX

Terex

$35.29

-0.3 (-0.84%)

19:01
02/22/19
02/22
19:01
02/22/19
19:01
Hot Stocks
Terex to sell Demag Mobile Cranes business to Tadano for $215M enterprise value »

Terex announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

CZR

Caesars

$9.05

-0.37 (-3.93%)

18:34
02/22/19
02/22
18:34
02/22/19
18:34
Hot Stocks
Canyon Partners: Caesars shareholders' value best served by open sale process »

Canyon Partners issued…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ERJ

Embraer

$20.85

0.17 (0.82%)

, BA

Boeing

$424.05

6.57 (1.57%)

18:11
02/22/19
02/22
18:11
02/22/19
18:11
Periodicals
Brazilian judge suspends Embraer-Boeing deal talks, Reuters reports »

A Brazilian judge…

ERJ

Embraer

$20.85

0.17 (0.82%)

BA

Boeing

$424.05

6.57 (1.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 11

    Mar

  • 14

    Mar

  • 28

    May

BXG

Bluegreen Vacations

$14.47

0.55 (3.95%)

18:02
02/22/19
02/22
18:02
02/22/19
18:02
Earnings
Bluegreen Vacations reports Q4 EPS 27c, consensus 24c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 22

    Feb

SM

SM Energy

$16.88

-0.13 (-0.76%)

17:57
02/22/19
02/22
17:57
02/22/19
17:57
Recommendations
SM Energy analyst commentary at MUFG »

SM Energy's higher…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AN

AutoNation

$37.22

-1.15 (-3.00%)

17:47
02/22/19
02/22
17:47
02/22/19
17:47
Syndicate
Breaking Syndicate news story on AutoNation »

AutoNation files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 22

    Feb

  • 27

    Feb

TSLA

Tesla

$294.60

3.42 (1.17%)

, NSANY

Nissan

$0.00

(0.00%)

17:42
02/22/19
02/22
17:42
02/22/19
17:42
Periodicals
Tesla's Model 3 was the highest-selling EV globally in 2018, Verge reports »

Tesla's (TSLA) Model…

TSLA

Tesla

$294.60

3.42 (1.17%)

NSANY

Nissan

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 18

    Mar

  • 19

    Mar

FSFG

First Savings Financial Group

$51.33

0.22 (0.43%)

17:31
02/22/19
02/22
17:31
02/22/19
17:31
Hot Stocks
First Savings Financial raises quarterly dividend to 16c per share from 15c »

The dividend will be paid…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSFT

Microsoft

$110.97

1.5 (1.37%)

17:31
02/22/19
02/22
17:31
02/22/19
17:31
Periodicals
Employees demand Microsoft cancel $480M U.S. Army contract, Reuters says »

Several Microsoft workers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 01

    Mar

  • 03

    Mar

  • 04

    Mar

  • 06

    Mar

  • 07

    Mar

  • 18

    Mar

ENT

Global Eagle

$2.66

(0.00%)

17:23
02/22/19
02/22
17:23
02/22/19
17:23
Hot Stocks
Global Eagle to cut workforce by roughly 15% »

As previously disclosed,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

17:15
02/22/19
02/22
17:15
02/22/19
17:15
General news
Breaking General news story  »

New York Federal Reserve…

NOC

Northrop Grumman

$288.84

2.54 (0.89%)

17:13
02/22/19
02/22
17:13
02/22/19
17:13
Hot Stocks
Northrop Grumman exec Kalan sells 4,312 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LYB

LyondellBasell

$89.14

0.63 (0.71%)

17:07
02/22/19
02/22
17:07
02/22/19
17:07
Syndicate
Breaking Syndicate news story on LyondellBasell »

LyondellBasell files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TCCO

Technical Comm Corp

$2.76

0.17 (6.56%)

17:06
02/22/19
02/22
17:06
02/22/19
17:06
Hot Stocks
Technical Comm Corp to submit plan to regain compliance with Nasdaq by March 4 »

Technical Comm Corp…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INFU

InfuSystem

$4.15

0.04 (0.97%)

17:01
02/22/19
02/22
17:01
02/22/19
17:01
Hot Stocks
InfuSystem announces settlement of derivative lawsuit »

InfuSystem Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KALU

Kaiser Aluminum

$108.22

-1.9 (-1.73%)

17:01
02/22/19
02/22
17:01
02/22/19
17:01
Hot Stocks
Kaiser Aluminum names Neal West as new CFO »

Kaiser Aluminum announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALDR

Alder Biopharmaceuticals

$14.35

0.19 (1.34%)

17:00
02/22/19
02/22
17:00
02/22/19
17:00
Hot Stocks
Alder Biopharmaceuticals submits eptinezumab BLA to FDA »

Alder BioPharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

RF

Regions Financial

$16.24

-0.01 (-0.06%)

16:59
02/22/19
02/22
16:59
02/22/19
16:59
Syndicate
Breaking Syndicate news story on Regions Financial »

Regions Financial files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 27

    Feb

HL

Hecla Mining

$2.59

-0.145 (-5.31%)

16:58
02/22/19
02/22
16:58
02/22/19
16:58
Syndicate
Breaking Syndicate news story on Hecla Mining »

Hecla Mining files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BMY

Bristol-Myers

$50.99

0.84 (1.68%)

, CELG

Celgene

$89.15

0.54 (0.61%)

16:52
02/22/19
02/22
16:52
02/22/19
16:52
Hot Stocks
Bristol-Myers files proxy statement in connection with proposed Celgene merger »

Bristol-Myers Squibb…

BMY

Bristol-Myers

$50.99

0.84 (1.68%)

CELG

Celgene

$89.15

0.54 (0.61%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 26

    Feb

  • 28

    Feb

  • 18

    May

  • 20

    May

  • 28

    May

TEN

Tenneco

$36.29

0.76 (2.14%)

16:48
02/22/19
02/22
16:48
02/22/19
16:48
Earnings
Tenneco sees FY19 revenue growth up 4%-5%, consensus $4.65B »

The company expects 2019…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.